Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages-Reference-Cited by-同舟云学术

Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages

Published:2021-11 Issue:11 Volume:24 Page:103328
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Gravel Caroline,Muralidharan Abenaya,Duran Amparo^ORCID,Zetner Adrian^ORCID,Pfeifle Annabelle^ORCID,Zhang Wanyue,Hashem Anwar^ORCID,Tamming Levi^ORCID,Farnsworth Aaron,Loemba Hugues^ORCID,Chen Wangxue^ORCID,Krammer Florian,Safronetz David,Cao Jingxin,Wang Lisheng,Sauve Simon^ORCID,Rosu-Myles Michael^ORCID,Van Domselaar Gary,Li Xuguang^ORCID

Funder

Government of Canada

Health Canada

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference71 articles.

1. The rationale for quadrivalent influenza vaccines;Ambrose;Hum. Vaccin. Immunother.,2012

2. A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus;Babon;J. Virol.,2012

3. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns;Bachmann;Nat. Rev. Immunol.,2010

4. Antigenic structure of the influenza B virus hemagglutinin: nucleotide sequence analysis of antigenic variants selected with monoclonal antibodies;Berton;J. Virol.,1984

5. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor;Bianchi;J. Virol.,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza B Virus Vaccine Innovation through Computational Design;Pathogens;2024-09-02

2. Multivalent Epigraph Hemagglutinin Vaccine Protects against Influenza B Virus in Mice;Pathogens;2024-01-23

3. Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses;Emerging Microbes & Infections;2023-05-09

4. Cross-Protection Induced by Virus-like Particles Derived from the Influenza B Virus;Biomedicines;2022-07-06

5. Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice;Human Vaccines & Immunotherapeutics;2022-06-20